Nyumbani › Vimeng'enya vya Ubongo
Majaribio ya kliniki ya Vimeng'enya vya Ubongo yanayovutia washiriki nchini Marekani
Masomo 197 ya Vimeng'enya vya Ubongo yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Houston, TXUtafiti 35
- Boston, MAUtafiti 28
- New York City, NYUtafiti 25
- Washington, DCUtafiti 20
- Los Angeles, CAUtafiti 16
- Miami, FLUtafiti 15
- Durham, NCUtafiti 14
- St. Louis, MOUtafiti 12
- Cleveland, OHUtafiti 11
- Seattle, WAUtafiti 11
- Rochester, MNUtafiti 11
- Columbus, OHUtafiti 11
- Baltimore, MDUtafiti 11
- Chicago, ILUtafiti 11
- Ann Arbor, MIUtafiti 10
- Aurora, COUtafiti 9
- Detroit, MIUtafiti 9
- Atlanta, GAUtafiti 9
- Nashville, TNUtafiti 8
- Arlington, VAUtafiti 8
- Minneapolis, MNUtafiti 8
- San Francisco, CAUtafiti 8
- Portland, ORUtafiti 8
- Dallas, TXUtafiti 8
- San Antonio, TXUtafiti 7
- Philadelphia, PAUtafiti 7
- San Diego, CAUtafiti 7
- Salt Lake City, UTUtafiti 7
- Mountain View, CAUtafiti 7
- Cincinnati, OHUtafiti 7
- Baldwin Park, CAUtafiti 7
- Jacksonville, FLUtafiti 7
- Tampa, FLUtafiti 6
- Birmingham, ALUtafiti 5
- Madison, WIUtafiti 5
- Winston-Salem, NCUtafiti 5
- Scottsdale, AZUtafiti 5
- Milwaukee, WIUtafiti 5
- Memphis, TNUtafiti 4
- Grand Rapids, MIUtafiti 4
Kwa jimbo
- AlabamaUtafiti 5
- ArizonaUtafiti 11
- ArkansasUtafiti 3
- CaliforniaUtafiti 39
- ColoradoUtafiti 11
- FloridaUtafiti 29
- GeorgiaUtafiti 12
- IdahoUtafiti 3
- IllinoisUtafiti 14
- IndianaUtafiti 4
- IowaUtafiti 4
- KansasUtafiti 3
- KentuckyUtafiti 5
- MarylandUtafiti 18
- MassachusettsUtafiti 29
- MichiganUtafiti 19
- MinnesotaUtafiti 18
- MissouriUtafiti 13
- MontanaUtafiti 3
- NebraskaUtafiti 5
- New HampshireUtafiti 4
- New JerseyUtafiti 8
- New YorkUtafiti 35
- North CarolinaUtafiti 20
- OhioUtafiti 23
- OklahomaUtafiti 3
- OregonUtafiti 8
- PennsylvaniaUtafiti 13
- Rhode IslandUtafiti 3
- South CarolinaUtafiti 5
- TennesseeUtafiti 12
- TexasUtafiti 42
- UtahUtafiti 8
- VirginiaUtafiti 15
- WashingtonUtafiti 12
- Wilaya ya ColumbiaUtafiti 13
- WisconsinUtafiti 11
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06991101Tumor Related Epilepsy
InaajiriUtafiti wa uchunguzi
Umri 8 hadi 99 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT02639325SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT05222620GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
InaajiriHatua 1
Umri 21 hadi 70 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06815432Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
InaajiriHatua 1/2
6 Months – 25 Years · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT04085887Evaluation and Treatment of Neurosurgical Disorders
InaajiriUtafiti wa uchunguzi
Umri 4 hadi 99 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT00060541Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07326566Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
InaajiriHatua 1/2
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07416188SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT04923542C-SMART vs BE Well for Patients With Brain Tumors
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07224503Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06047379RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
InaajiriHatua 1
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT06389591Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT05733312Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07248228Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07470606REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT07831772Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT04977375Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
InaajiriHatua ya kwanza ya awali
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06055790PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT07827001Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT07053033Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT07227610A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT05048212Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT05786924A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07492680A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT04511013Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.